PetMed Express, Inc. (PETS) Stock Faltering in Premarket, Here’s Why – News Heater
Home  »  Analyst Insight   »  PetMed Express, Inc. (PETS) Stock Faltering in Pre...

PetMed Express, Inc. (PETS) Stock Faltering in Premarket, Here’s Why

PetMed Express, Inc. (PETS), a company that operates as a pet pharmacy in the US, has declined 0.51% during the premarket trading session and consequently is trading at $23.50 at the time of the writing. On Monday, the stock closed the day at $23.62 after declining 1.62% during the regular trading session. The decline could be attributed to the announcement of quarterly results, as the reported earnings and revenue by the company have missed the estimates.

Why PETS Declining?

On Monday, PETS released the operational results for the third quarter of the fiscal year 2021. The quarter ended on 31st December 2021. The company generated net sales of $60.71 million during the quarter against $65.8 million for the same quarter of 2020. The total operating expenses bore by the company during the three months were $12.5 million against $10.3 million for the same three month period of 2020. The net income generated by the company during the period was $4.2 million (or $0.21 per basic and diluted share) against $7.6 million (or $0.38 per basic and diluted share) for the same period of 2020.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Financial Highlights

Alongside the operational results, PETS also released the financial highlights of the quarter. The company had cash and cash equivalents of $108.91 million on 31st December. The total current assets in possession of the company on the said date were $142.9 million, while the total assets were estimated to be $168.4 million. On the said date, the total current liabilities payable by the company were $26.2 million, while the total liabilities were estimated to be $27.5 million.

Executive Commentary

While commenting on the results, Matt Hulett, CEO and President of PETS said that the company is executing rapidly against its business transformation across people, process, and product. The future of the company is much broader than just a prescription eCommerce company. The company expects to show progress in the coming quarters as it is developing into a broader expert health and wellness offering.

Future Outlook for PETS

During the last three months, PETS stock has declined by approximately 12%. Looking forward, the analyst believes that there are no positive signals for the stock at the moment, so they are holding a negative evaluation of the stock looking well into the future. Potential investors should keep that in mind while deciding on their investment.

 

Leave a Comment

Your email address will not be published.

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam